DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2018 Update
- GDME1679PD
- Pages: 107
- June 2018
- Region : Europe
- GlobalData
- Equity Research Report
- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
Summary
DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company's products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DiaSorin S.p.A
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
DiaSorin S.p.A Company Overview 9
DiaSorin S.p.A Company Snapshot 9
DiaSorin S.p.A Pipeline Products and Ongoing Clinical Trials Overview 9
DiaSorin S.p.A-Pipeline Analysis Overview 13
Business Description 13
DiaSorin S.p.A-Key Facts 13
DiaSorin S.p.A-Major Products and Services 14
DiaSorin S.p.A Pipeline Products by Development Stage 15
DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19
DiaSorin S.p.A Pipeline Products Overview 21
BCR-ABL ABL Assay 21
BCR-ABL ABL Assay Product Overview 21
BCR-ABL P190 + ABL Assay 22
BCR-ABL P190 + ABL Assay Product Overview 22
BCR-ABL v1.5 Assay 23
BCR-ABL v1.5 Assay Product Overview 23
C-Kit 816 Assay 24
C-Kit 816 Assay Product Overview 24
C-Kit 822 Assay 25
C-Kit 822 Assay Product Overview 25
Diagnostic Assay-Atypical Pneumonia 26
Diagnostic Assay-Atypical Pneumonia Product Overview 26
Diagnostic Assay-Chronic Kidney Disease 27
Diagnostic Assay-Chronic Kidney Disease Product Overview 27
Diagnostic Assay-Enteric Infection 28
Diagnostic Assay-Enteric Infection Product Overview 28
Diagnostic Assay-Fecal Occult Blood Assay 29
Diagnostic Assay-Fecal Occult Blood Assay Product Overview 29
Diagnostic Assay-GI Inflammation 30
Diagnostic Assay-GI Inflammation Product Overview 30
Diagnostic Assay-Group B Streptococcus Infection 31
Diagnostic Assay-Group B Streptococcus Infection Product Overview 31
Diagnostic Assay-HBsAg High Throughput 32
Diagnostic Assay-HBsAg High Throughput Product Overview 32
Diagnostic Assay-HCV II 33
Diagnostic Assay-HCV II Product Overview 33
Diagnostic Assay-HSV M + cntr 34
Diagnostic Assay-HSV M + cntr Product Overview 34
Diagnostic Assay-Lactoferrin Assay 35
Diagnostic Assay-Lactoferrin Assay Product Overview 35
Diagnostic Assay-Lipase Assay 36
Diagnostic Assay-Lipase Assay Product Overview 36
Diagnostic Assay-Mycoplasma Genitalium Infection 37
Diagnostic Assay-Mycoplasma Genitalium Infection Product Overview 37
Diagnostic Assay-Streptococcus Pneumonia 38
Diagnostic Assay-Streptococcus Pneumonia Product Overview 38
Diagnostic Assay-Vaginosis 39
Diagnostic Assay-Vaginosis Product Overview 39
Diagnostic Assay-Vector Borne Diseases 40
Diagnostic Assay-Vector Borne Diseases Product Overview 40
Estradiol II Assay 41
Estradiol II Assay Product Overview 41
H.Influenza B Assay 42
H.Influenza B Assay Product Overview 42
Human Herpes Virus 6 IgG EIA Assay 43
Human Herpes Virus 6 IgG EIA Assay Product Overview 43
Human Herpes Virus 8 IgG IFA Assay 44
Human Herpes Virus 8 IgG IFA Assay Product Overview 44
Hyperphosphate-High Bone Turnover Assay 45
Hyperphosphate-High Bone Turnover Assay Product Overview 45
LAMP CBF-MYH D Assay 46
LAMP CBF-MYH D Assay Product Overview 46
LAMP CBF-MYH E Assay 47
LAMP CBF-MYH E Assay Product Overview 47
LAMP VCA IgA Assay 48
LAMP VCA IgA Assay Product Overview 48
LIAISON-Anti-HDV Assay 49
LIAISON-Anti-HDV Assay Product Overview 49
LIAISON-Chlamydia P. IgA Assay 50
LIAISON-Chlamydia P. IgA Assay Product Overview 50
LIAISON-Chlamydia P. IgG Assay 51
LIAISON-Chlamydia P. IgG Assay Product Overview 51
LIAISON-High Sclerostin Assay 52
LIAISON-High Sclerostin Assay Product Overview 52
LIAISON-Hyperphosphate Low Bone Turnover Assay 53
LIAISON-Hyperphosphate Low Bone Turnover Assay Product Overview 53
LIAISON-Tg Gen II Assay 54
LIAISON-Tg Gen II Assay Product Overview 54
LIAISON IAM-Acute Lymphoblastic Leukemia Test 55
LIAISON IAM-Acute Lymphoblastic Leukemia Test Product Overview 55
LIAISON IAM-Acute Promyelocytic Leukemia Test 56
LIAISON IAM-Acute Promyelocytic Leukemia Test Product Overview 56
LIAISON IAM-EBV Assay 57
LIAISON IAM-EBV Assay Product Overview 57
LIAISON IAM-Myeloproliferative Neoplasm Assay 58
LIAISON IAM-Myeloproliferative Neoplasm Assay Product Overview 58
LIAISON XL-Chlamydia Pneumoniae Assay 59
LIAISON XL-Chlamydia Pneumoniae Assay Product Overview 59
LIAISON XL-H. Pylori Ag Assay 60
LIAISON XL-H. Pylori Ag Assay Product Overview 60
LIAISON XL-H. Pylori Ag Assay Clinical Trial 61
LIAISON XL-Hepatitis A Assay 62
LIAISON XL-Hepatitis A Assay Product Overview 62
LIAISON XL-Hepatitis B Assay 63
LIAISON XL-Hepatitis B Assay Product Overview 63
LIAISON XL-Hepatitis C Assay 64
LIAISON XL-Hepatitis C Assay Product Overview 64
Liaison XL-HIV 65
Liaison XL-HIV Product Overview 65
LIAISON XL-Parvovirus B19 Test 66
LIAISON XL-Parvovirus B19 Test Product Overview 66
LIAISON XL-Sclerostin Assay 67
LIAISON XL-Sclerostin Assay Product Overview 67
LIAISON XL Zika Capture IgM Assay 68
LIAISON XL Zika Capture IgM Assay Product Overview 68
LIAISON XL- Procalcitonin Assay 69
LIAISON XL- Procalcitonin Assay Product Overview 69
LIAISON XS 70
LIAISON XS Product Overview 70
Neisseria meningitidis Assay 71
Neisseria meningitidis Assay Product Overview 71
Parvovirus B19 IFA Assay 72
Parvovirus B19 IFA Assay Product Overview 72
PML-RAR Alpha BCR2 Assay 73
PML-RAR Alpha BCR2 Assay Product Overview 73
PML-RAR1 + ABL Assay 74
PML-RAR1 + ABL Assay Product Overview 74
PML-RAR2 + ABL Assay 75
PML-RAR2 + ABL Assay Product Overview 75
PML-RAR3 + ABL Assay 76
PML-RAR3 + ABL Assay Product Overview 76
Progesterone II Assay 77
Progesterone II Assay Product Overview 77
Quant ABL Assay 78
Quant ABL Assay Product Overview 78
Quant BCR-ABL p210 Assay 79
Quant BCR-ABL p210 Assay Product Overview 79
Reagent ASRs-Gastro-intestinal Infections 80
Reagent ASRs-Gastro-intestinal Infections Product Overview 80
Reagent ASRs-Genetic Disorders 81
Reagent ASRs-Genetic Disorders Product Overview 81
Reagent ASRs-Immuno-Compromised Disorders 82
Reagent ASRs-Immuno-Compromised Disorders Product Overview 82
Reagent ASRs-Infectious Disease 83
Reagent ASRs-Infectious Disease Product Overview 83
Reagent ASRs-Respiratory Disease 84
Reagent ASRs-Respiratory Disease Product Overview 84
Reagent ASRs-Vector-Borne Disease 85
Reagent ASRs-Vector-Borne Disease Product Overview 85
Respiratory Virus Panel 86
Respiratory Virus Panel Product Overview 86
Simplexa Bordetella Direct 87
Simplexa Bordetella Direct Product Overview 87
Simplexa Enterovirus Direct 88
Simplexa Enterovirus Direct Product Overview 88
Simplexa MRSA Direct 89
Simplexa MRSA Direct Product Overview 89
DiaSorin S.p.A-Key Competitors 90
DiaSorin S.p.A-Key Employees 91
DiaSorin S.p.A-Key Employee Biographies 92
DiaSorin S.p.A-Locations And Subsidiaries 93
Head Office 93
Other Locations & Subsidiaries 93
Recent Developments 95
DiaSorin S.p.A, Recent Developments 95
May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 95
Apr 05, 2018: Diasorin Receives FDA Clearance For LIAISON BRAHMS PCT II GEN Assay To Detect Severe Bacterial Infections (Sepsis) 97
Mar 28, 2018: DiaSorin Earns FDA Clearance Extending Sample Claims For HSV 1 & 2 Test 97
Dec 12, 2017: Diasorin Launches A New Simplexa Bordetella Direct Molecular Test 98
Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 98
Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 99
Sep 21, 2017: Diasorin Earned CE-Mark Extending Sample Claims For Diasorin Molecular’s Simplexa HSV 1 & 2 Kit 99
Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 99
Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 102
Jul 10, 2017: Diasorin Launches IAM CBFB-MYH11, Completing The Diagnostic Test Menu For Molecular Screening Of Acute Myeloid Leukemia By Q-LAMP 103
Appendix 104
Methodology 104
About GlobalData 106
Contact Us 106
Disclaimer 107
List Of Figure
List of Figures
DiaSorin S.p.A Pipeline Products by Equipment Type 10
DiaSorin S.p.A Pipeline Products by Development Stage 15
DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19
List Of Table
List of Tables
DiaSorin S.p.A Pipeline Products and Ongoing Clinical Trials Overview 9
DiaSorin S.p.A Pipeline Products by Equipment Type 10
DiaSorin S.p.A Pipeline Products by Indication 11
DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 11
DiaSorin S.p.A, Key Facts 13
DiaSorin S.p.A, Major Products and Services 14
DiaSorin S.p.A Number of Pipeline Products by Development Stage 15
DiaSorin S.p.A Pipeline Products Summary by Development Stage 16
DiaSorin S.p.A Ongoing Clinical Trials by Trial Status 19
DiaSorin S.p.A Ongoing Clinical Trials Summary 20
BCR-ABL ABL Assay-Product Status 21
BCR-ABL ABL Assay-Product Description 21
BCR-ABL P190 + ABL Assay-Product Status 22
BCR-ABL P190 + ABL Assay-Product Description 22
BCR-ABL v1.5 Assay-Product Status 23
BCR-ABL v1.5 Assay-Product Description 23
C-Kit 816 Assay-Product Status 24
C-Kit 816 Assay-Product Description 24
C-Kit 822 Assay-Product Status 25
C-Kit 822 Assay-Product Description 25
Diagnostic Assay-Atypical Pneumonia-Product Status 26
Diagnostic Assay-Atypical Pneumonia-Product Description 26
Diagnostic Assay-Chronic Kidney Disease-Product Status 27
Diagnostic Assay-Chronic Kidney Disease-Product Description 27
Diagnostic Assay-Enteric Infection-Product Status 28
Diagnostic Assay-Enteric Infection-Product Description 28
Diagnostic Assay-Fecal Occult Blood Assay-Product Status 29
Diagnostic Assay-Fecal Occult Blood Assay-Product Description 29
Diagnostic Assay-GI Inflammation-Product Status 30
Diagnostic Assay-GI Inflammation-Product Description 30
Diagnostic Assay-Group B Streptococcus Infection-Product Status 31
Diagnostic Assay-Group B Streptococcus Infection-Product Description 31
Diagnostic Assay-HBsAg High Throughput-Product Status 32
Diagnostic Assay-HBsAg High Throughput-Product Description 32
Diagnostic Assay-HCV II-Product Status 33
Diagnostic Assay-HCV II-Product Description 33
Diagnostic Assay-HSV M + cntr-Product Status 34
Diagnostic Assay-HSV M + cntr-Product Description 34
Diagnostic Assay-Lactoferrin Assay-Product Status 35
Diagnostic Assay-Lactoferrin Assay-Product Description 35
Diagnostic Assay-Lipase Assay-Product Status 36
Diagnostic Assay-Lipase Assay-Product Description 36
Diagnostic Assay-Mycoplasma Genitalium Infection-Product Status 37
Diagnostic Assay-Mycoplasma Genitalium Infection-Product Description 37
Diagnostic Assay-Streptococcus Pneumonia-Product Status 38
Diagnostic Assay-Streptococcus Pneumonia-Product Description 38
Diagnostic Assay-Vaginosis-Product Status 39
Diagnostic Assay-Vaginosis-Product Description 39
Diagnostic Assay-Vector Borne Diseases-Product Status 40
Diagnostic Assay-Vector Borne Diseases-Product Description 40
Estradiol II Assay-Product Status 41
Estradiol II Assay-Product Description 41
H.Influenza B Assay-Product Status 42
H.Influenza B Assay-Product Description 42
Human Herpes Virus 6 IgG EIA Assay-Product Status 43
Human Herpes Virus 6 IgG EIA Assay-Product Description 43
Human Herpes Virus 8 IgG IFA Assay-Product Status 44
Human Herpes Virus 8 IgG IFA Assay-Product Description 44
Hyperphosphate-High Bone Turnover Assay-Product Status 45
Hyperphosphate-High Bone Turnover Assay-Product Description 45
LAMP CBF-MYH D Assay-Product Status 46
LAMP CBF-MYH D Assay-Product Description 46
LAMP CBF-MYH E Assay-Product Status 47
LAMP CBF-MYH E Assay-Product Description 47
LAMP VCA IgA Assay-Product Status 48
LAMP VCA IgA Assay-Product Description 48
LIAISON-Anti-HDV Assay-Product Status 49
LIAISON-Anti-HDV Assay-Product Description 49
LIAISON-Chlamydia P. IgA Assay-Product Status 50
LIAISON-Chlamydia P. IgA Assay-Product Description 50
LIAISON-Chlamydia P. IgG Assay-Product Status 51
LIAISON-Chlamydia P. IgG Assay-Product Description 51
LIAISON-High Sclerostin Assay-Product Status 52
LIAISON-High Sclerostin Assay-Product Description 52
LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Status 53
LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Description 53
LIAISON-Tg Gen II Assay-Product Status 54
LIAISON-Tg Gen II Assay-Product Description 54
LIAISON IAM-Acute Lymphoblastic Leukemia Test-Product Status 55
LIAISON IAM-Acute Lymphoblastic Leukemia Test-Product Description 55
LIAISON IAM-Acute Promyelocytic Leukemia Test-Product Status 56
LIAISON IAM-Acute Promyelocytic Leukemia Test-Product Description 56
LIAISON IAM-EBV Assay-Product Status 57
LIAISON IAM-EBV Assay-Product Description 57
LIAISON IAM-Myeloproliferative Neoplasm Assay-Product Status 58
LIAISON IAM-Myeloproliferative Neoplasm Assay-Product Description 58
LIAISON XL-Chlamydia Pneumoniae Assay-Product Status 59
LIAISON XL-Chlamydia Pneumoniae Assay-Product Description 59
LIAISON XL-H. Pylori Ag Assay-Product Status 60
LIAISON XL-H. Pylori Ag Assay-Product Description 60
LIAISON XL-H. Pylori Ag Assay-Helicobacter Pylori Sample Collection Protocol Post-therapy 61
LIAISON XL-H. Pylori Ag Assay-Helicobacter Pylori Sample Collection Protocol Pre-therapy 61
LIAISON XL-Hepatitis A Assay-Product Status 62
LIAISON XL-Hepatitis A Assay-Product Description 62
LIAISON XL-Hepatitis B Assay-Product Status 63
LIAISON XL-Hepatitis B Assay-Product Description 63
LIAISON XL-Hepatitis C Assay-Product Status 64
LIAISON XL-Hepatitis C Assay-Product Description 64
Liaison XL-HIV-Product Status 65
Liaison XL-HIV-Product Description 65
LIAISON XL-Parvovirus B19 Test-Product Status 66
LIAISON XL-Parvovirus B19 Test-Product Description 66
LIAISON XL-Sclerostin Assay-Product Status 67
LIAISON XL-Sclerostin Assay-Product Description 67
LIAISON XL Zika Capture IgM Assay-Product Status 68
LIAISON XL Zika Capture IgM Assay-Product Description 68
LIAISON XL- Procalcitonin Assay-Product Status 69
LIAISON XL- Procalcitonin Assay-Product Description 69
LIAISON XS-Product Status 70
LIAISON XS-Product Description 70
Neisseria meningitidis Assay-Product Status 71
Neisseria meningitidis Assay-Product Description 71
Parvovirus B19 IFA Assay-Product Status 72
Parvovirus B19 IFA Assay-Product Description 72
PML-RAR Alpha BCR2 Assay-Product Status 73
PML-RAR Alpha BCR2 Assay-Product Description 73
PML-RAR1 + ABL Assay-Product Status 74
PML-RAR1 + ABL Assay-Product Description 74
PML-RAR2 + ABL Assay-Product Status 75
PML-RAR2 + ABL Assay-Product Description 75
PML-RAR3 + ABL Assay-Product Status 76
PML-RAR3 + ABL Assay-Product Description 76
Progesterone II Assay-Product Status 77
Progesterone II Assay-Product Description 77
Quant ABL Assay-Product Status 78
Quant ABL Assay-Product Description 78
Quant BCR-ABL p210 Assay-Product Status 79
Quant BCR-ABL p210 Assay-Product Description 79
Reagent ASRs-Gastro-intestinal Infections-Product Status 80
Reagent ASRs-Gastro-intestinal Infections-Product Description 80
Reagent ASRs-Genetic Disorders-Product Status 81
Reagent ASRs-Genetic Disorders-Product Description 81
Reagent ASRs-Immuno-Compromised Disorders-Product Status 82
Reagent ASRs-Immuno-Compromised Disorders-Product Description 82
Reagent ASRs-Infectious Disease-Product Status 83
Reagent ASRs-Infectious Disease-Product Description 83
Reagent ASRs-Respiratory Disease-Product Status 84
Reagent ASRs-Respiratory Disease-Product Description 84
Reagent ASRs-Vector-Borne Disease-Product Status 85
Reagent ASRs-Vector-Borne Disease-Product Description 85
Respiratory Virus Panel-Product Status 86
Respiratory Virus Panel-Product Description 86
Simplexa Bordetella Direct-Product Status 87
Simplexa Bordetella Direct-Product Description 87
Simplexa Enterovirus Direct-Product Status 88
Simplexa Enterovirus Direct-Product Description 88
Simplexa MRSA Direct-Product Status 89
Simplexa MRSA Direct-Product Description 89
DiaSorin SpA, Key Employees 91
DiaSorin S.p.A, Key Employee Biographies 92
DiaSorin SpA, Other Locations 93
DiaSorin SpA, Subsidiaries 93
Glossary 105
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
DiaSorin S.p.A, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Trinity Biotech Plc
Roche Diagnostics SpA
Randox Laboratories Ltd
EKF Diagnostics Holdings Plc
Biohit Oyj
Related Reports
Page 152 | 
May 2019
Page 91 | December 2018
Page 40 | June 2018
Page 102 | June 2018
Page 54 | February 2018
